Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 04, 2019 12:00 ET | Source: Active Biotech

Extraordinary General Meeting of Active Biotech AB

PRESS RELEASE Lund Sweden, April 4 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) Extraordinary General Meeting of Active Biotech An Extraordinary General Meeting of Active Biotech AB (publ) was...
March 13, 2019 13:15 ET | Source: Active Biotech

KALLELSE TILL EXTRA BOLAGSSTÄMMA I ACTIVE BIOTECH AB (PUBL)

Aktieägarna i Active Biotech AB (publ) kallas till extra bolagsstämma torsdagen den 4 april 2019, kl. 17.00 i bolagets lokaler, Scheelevägen 22 i Lund. RÄTT TILL DELTAGANDERätt att delta i stämman...
March 13, 2019 13:15 ET | Source: Active Biotech

NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)

The shareholders of Active Biotech AB (publ) are invited to the Extraordinary Shareholders' Meeting to be held on Thursday April 4, 2019, at 5.00 pm in the Company's offices, Scheelevägen 22 in...
March 13, 2019 13:00 ET | Source: Active Biotech

Active Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on April 4, 2019

Lund Sweden, March 13 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that Active Biotech has entered into an agreement regarding sale of the Company's property Forskaren 1 in Lund,...
March 13, 2019 13:00 ET | Source: Active Biotech

Active Biotech har ingått avtal om överlåtelse av bolagets fastighet - extra bolagsstämma den 4 april 2019

Lund Sverige, 13 mars, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) tillkännager att Active Biotech har ingått avtal om överlåtelse av bolagets fastighet Forskaren 1 i Lund till ett nybildat...
February 14, 2019 02:30 ET | Source: Active Biotech

Active Biotech Bokslutsrapport januari - december 2018

Kvartal 4 i korthet Active Biotech lämnade uppdaterad information om bolagets finansiella ställning Nya data från LEGATO-HD studien presenteras på HSG 2018 Viktiga händelser i övrigt under...
February 14, 2019 02:30 ET | Source: Active Biotech

Active Biotech Year-end report January - December 2018

Fourth quarter in brief Active Biotech communicated updated information about its financial position New data from the LEGATO-HD study presented at the 2018 HSG conference Other...
February 11, 2019 08:00 ET | Source: Active Biotech

Active Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI® (durvalumab) in the upcoming Phase 1b/2 study

PRESS RELEASE Lund Sweden, February 11 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that their partner NeoTX enters a clinical collaboration with AstraZeneca Group Plc (NYSE: AZN)...
February 11, 2019 08:00 ET | Source: Active Biotech

Active Biotechs partner NeoTX inleder samarbete med AstraZeneca för att utvärdera ANYARA i kombination med IMFINZI® (durvalumab) i den planerade fas 1b/2 studien

PRESSMEDDELANDE Lund Sverige, 11 februari, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) tillkännager att dess partner NeoTX ingår ett kliniskt samarbete med AstraZeneca Group Plc's (NYSE: AZN)...
February 01, 2019 10:15 ET | Source: Active Biotech

Active Biotech har erhållit indikativt bud på fastigheten i Lund - styrelsen är positiv

Som tidigare redovisats har Active Biotechs fastighet Forskaren 1 i Lund under en period varit ute till försäljning. Active Biotech har nu erhållit ett indikativt, icke-bindande bud på fastigheten...